0000899243-15-010225.txt : 20151221 0000899243-15-010225.hdr.sgml : 20151221 20151221190027 ACCESSION NUMBER: 0000899243-15-010225 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151218 FILED AS OF DATE: 20151221 DATE AS OF CHANGE: 20151221 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Juno Therapeutics, Inc. CENTRAL INDEX KEY: 0001594864 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463656275 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 BUSINESS PHONE: 2066960703 MAIL ADDRESS: STREET 1: 307 WESTLAKE AVENUE NORTH, SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cassidy Bernard J CENTRAL INDEX KEY: 0001398322 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36781 FILM NUMBER: 151300465 MAIL ADDRESS: STREET 1: C/O TUMBLEWEED COMMUNICATIONS CORP STREET 2: 700 SAGINAW DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-12-18 0 0001594864 Juno Therapeutics, Inc. JUNO 0001398322 Cassidy Bernard J C/O 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 0 1 0 0 General Counsel and Secretary Common Stock 2015-12-18 4 S 0 1890 45.0182 D 71393 D Common Stock 2015-12-18 4 S 0 1310 45.9168 D 70083 D Common Stock 26869 I By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA This transaction was executed in multiple trades at prices ranging from $44.43 to $45.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $45.4926 to $46.14. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, in which the shares were sold through a trust for the sole benefit of the reporting person and his spouse. Includes 2,083 shares acquired under the issuer's employee stock purchase plan on November 16, 2015. /s/ Zachary Hale, attorney-in-fact 2015-12-21